IL-1 Signal Inhibition In Alcoholic Hepatitis (ISAIAH): a study protocol for a multicentre, randomised, placebo-controlled trial to explore the potential benefits of canakinumab in...

por N. Vergis, V. Patel, K. Bogdanowicz, J. Czyzewska-Khan, F. Fiorentino, E. Day, M. Cross, N. Foster, E. Lord, R. Goldin, E. Forrest, M. Thursz
Publicado 2021

Baseline renal functions predict the effect of canakinumab on regression of proteinuria in patients with familial Mediterranean fever

por Tolga Yildirim, Rahmi Yilmaz, Arzu Saglam, Muge Uzerk-Kibar, Jabrayil Jabrayilov, Yunus Erdem
Publicado 2021

The Efficacy, Safety and Tolerability of Canakinumab in the Treatment of Familial Mediterranean Fever: A Systematic Review of the Literature

por Kacar M, Savic S, van der Hilst JCH
Publicado 2020

Muckle–Wells syndrome: clinical perspectives

por Tran TA
Publicado 2017